SRPT
Sarepta Therapeutics is a global biotechnology company focused on precision genetic medicines to treat rare neuromuscular and central nervous system diseases. The company is advancing gene therapy and RNA-based approaches with an emphasis on Duchenne muscular dystrophy and related rare disorders, and is building manufacturing capacity to speed patient access. Headquartered with global operations, Sarepta collaborates across scientists, patients, and partners to bring transformative therapies to underserved populations.
No recent deals for this company.